CV

EDUCATION

1981-1985 Harvard Medical School (Pathology) and Dana-Farber Cancer Institute (Postdoctoral Fellowship)
1981  Ph.D. University of California, Irvine (Microbiology
1975  B.A. University of California, Los Angeles (Biology)

PROFESSIONAL EXPERIENCE

2012 – 2013 President, Cancer Biology Training Consortium
2010 – 2013 Board of Directors, Cancer Biology Training Consortium
2010 Consultant, Bristol-Myers Squibb
2010 Consultant, AstraZeneca
2010 Consultant, Sanofi-Aventis
2010 – 2012 Chair, Pancreatic Cancer Action Network –
AACR Innovative Grants Scientific Review Committee
2010 – 2011 AACR Program Committee
2009 – present Editorial Board, Bioscience Reports
2009 – present Editorial Board, Small GTPases
2009 – present Editorial Board, Genes & Cancer
2008 Senior Academic Visitor of Wolfson College, Cambridge, UK
2008 – present Scientific Advisory Board, Lustgarten Foundation for
Pancreatic Cancer Research
2008 – present Consultant, Millipore
2007 – 2011 Reviewer, Italian Association Cancer Research
2007 – 2008 AACR Program Committee
2007 – 2008 Member, Children’s Tumor Foundation, Drug Discovery Initiative Panel
2007 Member, AACR Grants Subcommittee for
Pancreatic Cancer Research Fellowship
2006 – 2009 Member, DOD Neurofibromatosis Research Program Integration Panel
2006 – present Editorial Board, Journal Molecular Signaling
2004 – 2007 AACR Laboratory Research Awards Selection Committee
2005 – present Member, Cancer Biology Training Consortium
2003 Consultant, Chemicon
2003 Consultant, Upstate Biotechnology
2003 Consultant, Odyssey Thera
2002 Consultant, PPD Discovery
2001- present Member, Faculty of 1000
2001 External Reviewer, Wake Forest Cancer Center Program
2000 – 2002 Associate Editor, Cancer Research
2000 – present Editorial Board, Cancer Letters
2000 – present Consultant, Tularik
1998 – present Director, NIH Cancer Cell Biology Training Grant
1998 – present Board of Advisors, Children’s Tumor Foundation
1998 – present Member, Curriculum in Toxicology, UNC-Chapel Hill
1998 Consultant, Schering-Plogh
1997 Consultant, Dupont-Merck
1996 – 1997 Consultant, Biomeasure
1996 Consultant, Merck
1995 -1996 Consultant, Parke-Davis
1995 – present Professor, Department of Pharmacology, Member,
UNC Lineberger Comprehensive Cancer Center and

Member,
Curriculum in Genetics and Molecular Biology,
University of North Carolina at Chapel Hill

1992-1995 Associate Professor, Department of Pharmacology, Member,
UNC Lineberger Comprehensive Cancer Center and

Member,
Curriculum in Genetics and Molecular Biology,
University of North Carolina at Chapel Hill

1992-1996 Member, NIH Pathology B Study Section
1992-1994 Consultant, Bristol-Myers Squibb
1992-1993 Consultant, Dupont Merck Pharmaceuticals
1991-1993 Consultant, Eisai Research Institute
1990-pre. Consultant, Special Review Committee, NCI
1989-1991 Ad Hoc Member, NIH Pathology B Study Section
1989-1992 Staff Scientist, The Burnham Institute
1985-1989 Assistant Staff Scientist, The Burnham Institute
1981-1985 Postdoctoral Fellow, Harvard Medical School and the Dana-Farber Cancer Institute
Advertisements

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s